AMPLITUDENMODULATION FÜR TUMORBEHANDLUNGSFELDER

Patent europeic · EP4271467 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4271467
Numer da la dumonda
EP21848460
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
29-12-2021
Publitgà
08-11-2023
Concedì
01-04-2026
La protecziun finescha il pli tard
28-12-2041
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
A61N 1/36 (2006.01)
A61N 1/06 (2006.01)
Prioritad
US 202063132307 P 30.12.2020
Dumonda PCT
PCT/US2021/065550 29.12.2021
Publicaziun PCT
WO2022/147153 07.07.2022
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.04.2026

Partidas

Possessur

Novocure GmbH

NOVOCURE GMBH

Neuhofstrasse 21, 6340 Baar

Inventur

CARLSON, Kristen, W.

Concord, MA 01742, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.